Governance
Shareholders' Rights
Shareholders’ Rights
Status of Major Shareholders
All stocks of SK bioscience are common stock, and our largest shareholder is SK chemicals, which owns 68.18% of the shares as of December 31, 2022.
SK bioscience Major Shareholders and Related Parties Share Structure
Major Shareholders and Related Parties Share Structure
| Category | Shareholder Name | Number of Shares Owned | Share Ratio |
|---|---|---|---|
| 5% or more Shareholders | SK chemicals | 52,353,000 | 68.18% |
| Others | 24,434,046 | 31.82% | |
| Total | 76,784,046 | 100% | |
Protection of Shareholders’ Rights
Introduction of Electronic Voting System
SK bioscience operates several shareholder rights protection systems to safeguard shareholders’ rights and interests in corporate management while strengthening investors’ awareness of their rights. In 2021, we resolved to introduce an electronic voting system to maximize the exercise of shareholders’ voting rights and adopted it at the General Meetings of Shareholders in 2022 and 2023. Additionally, we provide transparent disclosure of our share status through various channels, including SK bioscience’s website and electronic disclosure system.
Annual General Meetings
SK bioscience holds an annual general meeting of shareholders to share the company’s direction and management status with shareholders and stakeholders and to collect their feedback. In accordance with Article 542-4 of the Commercial Act, we notify and disclose matters concerning the venue and agenda of the annual general meeting two weeks in advance. In 2023, a convening notice was issued 24 days prior to the meeting. Resolutions passed at the meeting or major agenda items that are closely related to investors’ interests are disclosed on the Data Analysis, Retrieval, and Transfer System(DART). Furthermore, the status of the exercise of voting rights at the General Meeting of Shareholders held on March 27, 2023(including the number of voting rights in attendance) is also available on SK bioscience’s website.
Efforts to Communicate with Shareholders
The most important aspect of corporate governance is communication between the company and its shareholders. We transparently disclose our management status and performance to our shareholders not only through the general meeting of shareholders, but also through performance presentations, regular IR meetings, and domestic & global Non-Deal Roadshows(NDRs). Information necessary for shareholders, such as shareholder status, stock issuance history, performance announcements, Analyst Reports, etc. are disclosed on SK bioscience’s website. Through active IR activities and continuous communication with analysts, SK bioscience will strive to provide useful investment-related information to shareholders and actively utilize it in management’s decision-making.